aTyr Pharma Inc expected to post a loss of 38  cents a share - Earnings Preview

aTyr Pharma

12/08/2022 23:08

* aTyr Pharma Inc  LIFE.OQ   LIFE.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 15. 
    * The San Diego California-based  company is expected to
report
revenue of $2 million, according to the mean estimate from 5
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for aTyr Pharma Inc is
for a
loss of 38 cents per share. For the same quarter last year, the
company reported a loss of 64 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $20​, above​ its last closing price of $3.54. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.33       -0.33      -0.44     Missed  -32.7
 Dec. 31 2022              -0.28      -0.31     Missed  -9.4
 Sep. 30 2021  -0.65       -0.60      -0.42     Beat    29.5​
 Jun. 30 2021  -0.50       -0.51      -0.64     Missed  -26
 ​​Mar.        -0.40       -0.32      -0.51     Missed  -60.6
 31 2021                                                
 Dec. 31 2020  -0.83       -0.82      -0.47     Beat    42.9​
 Sep. 30 2020  -0.74       -0.74      -0.68     Beat    8.5
 Jun. 30 2020  -0.74       -0.73      -0.69     Beat    5.5
 This summary was machine generated August 12 at 22:08 GMT.  All
figures in US dollars  unless otherwise stated